Lauren Merendino is Chief Commercial Officer of Myovant Sciences Ltd.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
ESSA Pharma Inc.
28 Mar 24
3
ESSA Pharma Inc.
6 Jun 23
4
Myovant Sciences Ltd.
10 Mar 23
4
Myovant Sciences Ltd.
20 Jan 23
4
Myovant Sciences Ltd.
20 Oct 22
4
Myovant Sciences Ltd.
20 Jul 22
4
Myovant Sciences Ltd.
21 Apr 22
4
Myovant Sciences Ltd.
19 Apr 22
4
Myovant Sciences Ltd.
19 Apr 21
3
Myovant Sciences Ltd.
8 Apr 21
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
25 Mar 24 | EPIX Essa Pharma | Options Common Shares | Grant | Acquire A | No | No | 9.04 | 25,000 | 226.00 k | 25,000 |
10 Mar 23 | MYOV Myovant Sciences | Common Shares | Sale back to company | Dispose D | No | No | 0 | 147,747 | 0.00 | 0 |
10 Mar 23 | MYOV Myovant Sciences | Common Shares | Sale back to company | Dispose D | No | No | 0 | 21,791 | 0.00 | 147,747 |
10 Mar 23 | MYOV Myovant Sciences | Performance Stock Unit Common Shares | Sale back to company | Dispose D | No | No | 0 | 103,703 | 0.00 | 0 |
10 Mar 23 | MYOV Myovant Sciences | Stock Options Common Shares | Sale back to company | Dispose D | No | No | 17.88 | 123,300 | 2.20 mm | 0 |
18 Jan 23 | MYOV Myovant Sciences | Common Shares | Sell | Dispose S | No | No | 26.89 | 2,008 | 54.00 k | 169,538 |